Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
The First Affiliated Hospital of Xinxiang Medical College
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT06182800
Assets
Linked programs
- Adebrelimab Combined with Bevacizumab and Docetaxel: Timeline Staleness Signal (4/5)